Abstract
Administration of anti-cholinesterase before operation and high doses of prednisolone after the operation are commonly prescribed in cases of thymectomy for the treatment of myasthenia gravis. Our policy is to carry out an extended thymectomy combined with pre- and post-operative administration of prednisolone on alternate days. Our method was used in the treatment of 50 patients with generalized myasthenia gravis, from January 1979 to December 1984. The results were examined in conjunction with the necessity for preoperative administration of an anti-cholinesterase preparation and also with factors influencing the follow-up result and postoperative process. This method made it feasible to perform surgery under conditions of stabilization of clinical symptoms and satisfactory postoperative management. A postoperative period of unstable symptoms could thus be avoided. The palliation rate at one year after the operation was 96 per cent, while the remission rate at 5 years after the operation was 70 per cent. The preoperative supplement of anti-cholinesterase and preoperative per cent forced vital capacity were considered to be predictive factors concerning the necessity of artificial respiration.
Similar content being viewed by others
References
Blalock A, Mason MF, Morgan HJ, Riven SS. Myasthenia gravis and tumors of the thymic region, report of a case in which the tumor was removed. Ann Surg 1939; 110: 544–561.
Buckingham JM, Frank BS, Howard M, Bernaty P, Spencerpayne W, Harrison EG, O'Brien PC, Weiland LH. The value of thymectomy in myasthenia gravis; a computer-assisted matched study. Ann Surg 1976; 184: 453–458.
Ito N. Treatment of myasthenia gravis pathophysiological evaluation of various forms of treatment and practical aspects of therapy. Brain and Nerve 1980; 32: 921–929.
Seybold ME, Drachman DB. Gradually increasing doses of prednisone in myasthenia gravis. N Engl J Med 1974; 290: 81–84.
Osserman KE, Genkins GC. Studies in myasthenia gravis, a review of twenty years' experience in over 1200 patients. Mt Sinai J Med (NY) 1971; 38: 497–537.
Noble MD, Peacock JH, Lacher JA, Hofmann WW. Prednisolone-neostigmine interactions at cholinergic junctions. Muscle and Nerve 1979; 2: 155–157.
Douglous RG, Matthew BD, Frank MH, Spencer WP. Postoperative respiratory care after transsternal thymectomy in myasthenia gravis.—A 3-year experience in 53 patients—Chest 1984; 86: 67–71.
Edward DS, Atul M, Maurice H, Delos MC. Post-operative ventilatory dependency following thymectomy for myasthenia gravis. Cleveland Clinic Quarterly 1984; 51, 4: 585–589.
Younger DS, Braun NMT, Jaretzki A, Penn AS, Lovelace RE. Myasthenia gravis: determinants for independent ventilation after transsternal thymectomy. Neurology 1984; 34: 336–340.
Leventhal SR, Orkin FK, Hirsh RA. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology 1980; 53: 26–30.
Ohshima F. Review on clinical progress of myasthenia gravis after thymectomy and significance of corticosteroid therapy. Clinical Neurology 1981; 21: 117–125.
Masaoka A, Monden Y. Comparison of the results of transsternal simple, transcervical simple and extended thymectomy. Ann NY Acad Sci 1981; 377: 755–763.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamaguchi, Y., Saito, Y., Baba, M. et al. Favorable results of thymectomy combined with prednisolone alternate-day administration in myasthenia gravis. The Japanese Journal of Surgery 17, 14–20 (1987). https://doi.org/10.1007/BF02470579
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470579